Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Cancer: Page 3
Hologic receives FDA clearance for digital cytology scanner platform in U.S.
By
Liz Carey
Acknowledging human papillomavirus (HPV) as a causative agent for cervical cancer, the new system is designed to complement molecular testing for HPV with cotesting for cervical cancer.
February 2, 2024
DermTech to lay off 30 employees, take further restructuring measures
By
LabPulse.com staff writers
DermTech will lay off 30 employees and take additional restructuring measures to cut operating expenses, streamline operations, and focus its resources on revenue growth.
February 1, 2024
FDA orders new info warnings on CAR-T therapies
By
LabPulse.com staff writers
Following its review of reports of T-cell malignancies associated with the administration of six CAR-T immunotherapies, the FDA has instructed the manufacturers to include warnings in the prescribing info for the therapeutics.
January 30, 2024
Study uncovers role of genetic variants in blood cancer development
By
Matt Limb
Scientists have used large scale data analysis to investigate why only some people with a common mutation go on to develop rare blood cancer.
January 23, 2024
Genetic-informed model improves prediction of blood cancer prognosis
By
Nick Paul Taylor
Researchers have used genetic, treatment, and clinical data to improve prediction of the prognosis of patients with multiple myeloma.
January 18, 2024
Weill Cornell study may support new prognostic test for prostate tumor spread
By
LabPulse.com staff writers
Scientists working in the department of pathology and laboratory medicine at Weill Cornell Medicine have found that certain noncancerous cells may be useful for assessing prostate tumors and their potential to spread.
January 16, 2024
Geneoscopy requests review of Exact Sciences patent, dismissal of lawsuit
By
LabPulse.com staff writers
In the latest development in the patent infringement dispute between the two companies, Geneoscopy has petitioned the U.S. Patent and Trademark Office for inter partes review, challenging the patent in contention held by Exact Sciences.
January 12, 2024
Bristol Myers Squibb to acquire RayzeBio for $4.1B
By
LabPulse.com staff writers
In its second multibillion-dollar acquisition announced within a week, Bristol Myers Squibb will acquire RayzeBio, which develops radiopharmaceutical cancer therapeutics, in an agreement worth approximately $4.1 billion.
December 27, 2023
Owkin and MSD to collaborate on cancer diagnostics
By
LabPulse.com staff writers
Biotech firm Owkin has formed a collaboration with MSD (Merck) to develop and commercialize AI-powered digital microsatellite instability high (MSI-H) pathology cancer diagnostics for EU markets.
December 19, 2023
$3.6M grant to study oral cancer saliva detection test
By
Melissa Busch
The Moffitt Cancer Center in Florida has received a $3.6 million grant to evaluate an oral gargle test that could be used to screen for oropharyngeal cancer during routine dental checkups.
December 11, 2023
Guardant Health, Cancer Research UK partner on data and research
By
LabPulse.com staff writers
London-based Cancer Research UK and its innovation unit, Cancer Research Horizons, are collaborating with Guardant Health on sharing technology, data, and research insights for advancing cancer detection and treatment.
December 5, 2023
Court issues injunction against Invitae, ArcherDx in Natera patent infringement suit
By
LabPulse.com staff writers
The U.S. District Court for the District of Delaware has issued a permanent injunction against Invitae and its subsidiary ArcherDx, ordering them to stop using products containing material patented by Natera.
December 4, 2023
Previous Page
Page 3 of 96
Next Page
